Literature DB >> 32360941

Effective Reproductive Number estimation for initial stage of COVID-19 pandemic in Latin American Countries.

Yaset Caicedo-Ochoa1, David E Rebellón-Sánchez2, Marcela Peñaloza-Rallón3, Hector F Cortés-Motta4, Yardany R Méndez-Fandiño5.   

Abstract

OBJECTIVES: The coronavirus disease 2019 (COVID-19) has become pandemic and turn in a challenge for Latin America. Understanding the dynamics of the epidemic is essential for decision making, and to reduce the health, economic, and social impacts of the pandemic. The present study aimed to estimate the effective reproductive number (Rt) of Severe Acute Respiratory Syndrome coronavirus 2 (SARS-Cov2) infection during the first 10 days of the outbreak in seven Latin American countries with the highest incidence of cases as of March 23, 2020. Furthermore, we chose to compare the seven countries with Spain and Italy given their history with the virus.
METHODS: Incidence data retrieved from the COVID-19 data repository by Johns Hopkins University were analyzed. The Rt was calculated for the first 10 days of the epidemic in Brazil, Ecuador, Chile, Colombia, Panama, Mexico, and Peru. Rt estimations were compared with Spain and Italy values for the same interval.
RESULTS: The median Rt for the first 10 days of the COVID-19 epidemic were 2.90 (2.67-3.14) for Spain and 2.83 (2.7-2.96) for Italy. Latin American Rt estimations were higher in Ecuador (3.95(3.7-4.21)), Panama (3.95(3.7-4.21)), and Brazil (3.95(3.7-4.21)). The smallest one was observed in Peru (2.36(2.11-2.63)). All Latin American countries had Rt greater than 2.
CONCLUSIONS: The initial stages of the COVID-19 epidemic in Latin America suggested a high Rt. Interventions such as domestic and international travel restrictions, educational institutions closure, social distancing, and intensified case surveillance should be adopted to prevent the collapse of the health systems.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2020        PMID: 32360941      PMCID: PMC7192078          DOI: 10.1016/j.ijid.2020.04.069

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


Introduction

In December 2019, Severe Acute Respiratory Syndrome (SARS) with an unknown etiology was reported in Wuhan City, Hubei Province, China. A novel coronavirus disease 2019 (COVID-19) was rapidly identified and characterized (Zhu et al., 2020). In a three-month lapse and despite intense containment measures, COVID-19 cases worldwide have continually increased. On March 11, 2020, the WHO declared the coronavirus a pandemic. At present, more than two million people have been infected worldwide, with the highest incidences appearing in Asia, Europe, and North America. Health systems around the world have collapsed, and mortality rates have reached overwhelming numbers in high income countries (World Health Organization, 2020). The first COVID-19 case in Latin America was detected in Brazil on February 26, 2020 (Rodriguez-Morales et al., 2020). Since then, more cases have been showing up all around Latin America. In order to mitigate the effects of COVID-19 and make appropriate decisions related to the health, economic, and social system, it is crucial to understand the nature of the outbreak. Modeling studies are useful in understanding epidemics and evaluating the potential impact of interventions in the early stages of pandemics. The Effective Reproductive number (Rt) is a parameter that can be used to follow-up the epidemics (de Silva et al., 2009, Nishiura et al., 2016, Koo et al., 2020). Rt is different from the basic reproductive number (R0). The R0 is the expected number of secondary cases from a primary case in a population where everyone is susceptible. During the course of the epidemic, some individuals become infected or immune and are no longer susceptible; therefore, the estimation of Rt is more appropriate. Rt is calculated as a function of time and is the actual average number of secondary cases per primary case (Wallinga, 2004). The Rt number will usually be smaller than the Ro number because it takes into account the impact of control measures and non-susceptible individuals in the population (de Silva et al., 2009, Cori et al., 2013, Delamater et al., 2019). Currently, governments in Latin America have taken measures to mitigate the spread of COVID-19 primarily based on world health organization recommendations. However, the potential impact of the virus in Latin America is still unknown. The first cases in Latin America were reported months after the virus spread in China, Italy, Spain, and North America. Given the urgency in these countries, governments need more accurate estimates of what could happen in Latin America in order to make informed decisions. The present study estimated the Rt of SARS-Cov2 during the first 10 days of the outbreak in seven Latin American countries and compared it to the Rt in Spain and Italy.

Material and Methods

Data Source

Time-dependent incidence data were retrieved from the 2019 Novel Coronavirus COVID-19 Johns Hopkins University data repository (Dong et al., 2020). Brazil, Ecuador, Chile, Colombia, Panama, Mexico, and Peru were selected because they had been through 10 days of the outbreak, as well as having the highest incidence of cases in Latin America as of March 23, 2020. We chose to compare the Latin American Rt values with Spain and Italy because they had similar population numbers to the Latin American countries. Additionally, Spain and Italy were among the most affected countries in Europe due to COVID-19 (Yuan et al., 2020).

Data analysis

To calculate Rt values, we used the same methodology of Cori et al (Cori et al., 2013). Rt was estimated by the ratio of the number of new infections generated in step t, It, to the total infectiousness of infected individuals at time t, given by , the sum of infection incidence up to the time step t - 1, weighted by the infectivity function w . Rt values equal or below one indicates that there will be a decline in the number of cases. Rt values higher than one indicate that the number of cases will increase. Contact traces and transmissibility can change over time in regard to the outbreak progression. Rt values can be adjusted to include a serial interval (SI) as the infectivity function, under the assumption of a gamma distribution (Wallinga, 2004, Cori et al., 2013). We estimated two scenarios: a) An Rt estimated using the SI calculated by (Li et al., 2020) for the early transmission in the Wuhan's outbreak (mean SI of 7.5 days, and standard deviation (SD) of 3.4 days). b) An Rt estimated using the SI calculated by (Nishiura et al., 2020) through Bayesian statistics of exponential growth rate adjusted by the growth of curve during the initial stage of the outbreak (Mean SI: 4.7 days. SD SI: 2.9 days). Analytical estimates of the Rt were obtained within a Bayesian framework. Rt was estimated in a 10 days interval from the date that a cumulative incidence of 25 or more cases of COVID-19 was reached in each country. The choice of the 25 cases of cumulative incidence is to goal a coefficient of variation of 0.2 in each time window (Cori et al., 2013). We reported the median and 95% credible interval (CI). Additionally, we report how many days it took to reach the incidence of 25 cases in each country. Statistical analysis was performed using R language version 3.6.3 (R Core Team, 2019).

Results

The interval of days required to reach 25 cumulative cases was divergent in Latin American countries compared with European referents. While 22 and 25 days were required in Italy and Spain, respectively, the interval in Latin America ranged from 3 days in Panama to 15 days in Mexico. Rt estimates in the first 10 days after reach the 25 cumulative incidence are described in Table 1 . All Latin American countries had Rt greater than 2. Ecuador and Panama had the highest Rt values of Latin America, while Peru had the lowest. Rt estimates for Ecuador, Panama, and Brazil were higher than both European referents. Spain and Italy had higher Rt values than Mexico, Colombia, Peru, and Chile (Fig. 1 ).
Table 1

Effective reproductive number (Rt) estimates for Latin American countries, Italy and Spain.

CountryDate in which each country completes at least 25 cases of cumulative incidenceThe interval between the start of the outbreak and the cumulative incidence > - 25 cases (days)Rt in the first 10-day using SI of Li et al Median (95% Credible Interval)Rt in the first 10-day using SI of Nishiura et al Median (95% Credible Interval)
Spain26-February256.48(5.97-7.02)2.90(2.67-3.14)
Italy22-February226.41(6.11-6.71)2.83(2.70-2.96)
Ecuador14-March1312.86 (12.05-13.69)3.95 (3.70-4.21)
Panama13-March37.19(6.37-8.08)3.67(3.25-4.13)
Brazil09-March126.53(5.85-7.25)2.91(2.60-3.23)
Chile13-March105.79(5.32-6.28)2.67(2.45-2.89)
Colombia15-March95.65(5.04-6.29)2.67(2.38-2.98)
Peru13-March75.24(4.68-5.83)2.36(2.11-2.63)
Mexico12-March154.94(4.37-5.56)2.42(2.14-2.72)
Fig. 1

Comparison of Rt estimates for Latin American countries, Italy and Spain using two different serial intervals.

Effective reproductive number (Rt) estimates for Latin American countries, Italy and Spain. Comparison of Rt estimates for Latin American countries, Italy and Spain using two different serial intervals.

Discussion

Important variations were observed when the Rt was calculated using the parameters of (Li et al., 2020) or (Nishiura et al., 2020). The differences between both serial intervals are related to the infectious probability time, which was higher for Li et al. To analyze the initial phases of the outbreak, we preferred to use Nishiuria et al.’s (2020) parameters. The findings using these parameters show more conservative scenarios and less variation than previous studies made in other regions of the world (Yuan et al., 2020, Zhang et al., 2020). The Rt estimates in the first ten days of the COVID-19 pandemic were higher in some of the Latin American countries compared to the European referents. The aggressive dynamics of the outbreak in countries such as Brazil, Ecuador and Panama should be considered by surveillance systems in order to provide a quick response and stricter containment strategies. Despite the fact that the estimated Rt for Colombia, Peru, Chile and Mexico were lower than the European ones, the variation with respect to them is minimal. All Latin American countries had Rt greater than 2, indicating an exponential growth. There is a high probability that the capacity of the Latin American healthcare systems is overwhelmed. Furthermore, the COVID-19 pandemic could have serious repercussions in the region, given the context of politically divided countries, social inequality, economic limitations, internal conflicts, and social protests (Rodriguez-Morales et al., 2020). Although containment strategies have been implemented in some countries to mitigate the impact of the pandemic, additional interventions should be prioritized to attenuate the consequences of the outbreak and prevent similar scenarios observed in Spain and Italy. Domestic and international travel restrictions, educational institutions closure, elderly isolation, compulsory social distancing, and intensified case surveillance are strategies that may attenuate the consequences of COVID-19 (Koo et al., 2020). Potential limitations in interpreting our results are associated with underestimation or overestimation of Rt measurements. These may vary based on available diagnostic tests, the inclusion of imported cases in the early stages of the outbreak, and delays in reporting cases by health institutes (de Silva et al., 2009, Cori et al., 2013). Under ideal conditions, Rt should be calculated using the date of the onset of symptoms and not the diagnostic report date. However, none real-time available data sources have this information for the region. In the current scenario, calculating an approximate Rt using the date of diagnostic report is a useful tool, and provides valuable information on the dynamics of the outbreak in its initial stages. In conclusion, the COVID-19 outbreak represents a real threat to low-income countries like those in Latin America. Rt estimation for initial stage of COVID-19 pandemic in Latin American countries shows an aggressive dynamic of outbreak and suggest a grim scenario. Capacity development, intensified surveillance, and human, financial and infrastructure resources must be prioritized urgently.

Funding sources

No funding was received for this study.

Ethical Approval

This research does not involve human subjects. It is not required to obtain Institutional Review Board (IRB) approval.

Conflict of interest

The authors declare not to have any conflict of interest.
  13 in total

1.  Complexity of the Basic Reproduction Number (R0).

Authors:  Paul L Delamater; Erica J Street; Timothy F Leslie; Y Tony Yang; Kathryn H Jacobsen
Journal:  Emerg Infect Dis       Date:  2019-01       Impact factor: 6.883

2.  Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis.

Authors:  Sheng Zhang; MengYuan Diao; Wenbo Yu; Lei Pei; Zhaofen Lin; Dechang Chen
Journal:  Int J Infect Dis       Date:  2020-02-22       Impact factor: 3.623

3.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

4.  COVID-19 in Latin America: The implications of the first confirmed case in Brazil.

Authors:  Alfonso J Rodriguez-Morales; Viviana Gallego; Juan Pablo Escalera-Antezana; Claudio A Méndez; Lysien I Zambrano; Carlos Franco-Paredes; Jose A Suárez; Hernan D Rodriguez-Enciso; Graciela Josefina Balbin-Ramon; Eduardo Savio-Larriera; Alejandro Risquez; Sergio Cimerman
Journal:  Travel Med Infect Dis       Date:  2020-02-29       Impact factor: 6.211

5.  Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures.

Authors:  Jacco Wallinga; Peter Teunis
Journal:  Am J Epidemiol       Date:  2004-09-15       Impact factor: 4.897

6.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

7.  An interactive web-based dashboard to track COVID-19 in real time.

Authors:  Ensheng Dong; Hongru Du; Lauren Gardner
Journal:  Lancet Infect Dis       Date:  2020-02-19       Impact factor: 25.071

8.  Serial interval of novel coronavirus (COVID-19) infections.

Authors:  Hiroshi Nishiura; Natalie M Linton; Andrei R Akhmetzhanov
Journal:  Int J Infect Dis       Date:  2020-03-04       Impact factor: 3.623

9.  Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study.

Authors:  Joel R Koo; Alex R Cook; Minah Park; Yinxiaohe Sun; Haoyang Sun; Jue Tao Lim; Clarence Tam; Borame L Dickens
Journal:  Lancet Infect Dis       Date:  2020-03-23       Impact factor: 25.071

10.  Monitoring transmissibility and mortality of COVID-19 in Europe.

Authors:  Jing Yuan; Minghui Li; Gang Lv; Z Kevin Lu
Journal:  Int J Infect Dis       Date:  2020-03-28       Impact factor: 3.623

View more
  23 in total

1.  A guide to R - the pandemic's misunderstood metric.

Authors:  David Adam
Journal:  Nature       Date:  2020-07       Impact factor: 49.962

2.  Coronavirus Awareness and Mental Health: Clinical Symptoms and Attitudes Toward Seeking Professional Psychological Help.

Authors:  Miguel Landa-Blanco; Ana Landa-Blanco; Claudio J Mejía-Suazo; Carlos A Martínez-Martínez
Journal:  Front Psychol       Date:  2021-04-22

3.  The impact of SARS-CoV-2 in dementia across Latin America: A call for an urgent regional plan and coordinated response.

Authors:  Agustin Ibanez; Hernando Santamaria-Garcia; Alejandra Guerrero Barragan; Alexander Kornhuber; Alyne Mendonca Marques Ton; Andrea Slachevsky; Antonio Lucio Teixeira; Beatriz Marcela Mar Meza; Cecilia M Serrano; Carlos Cano; Carolina Arias Gonzalez; Christian Gonzalez-Billault; Christopher Butler; Julian Bustin; Claudia Duran-Aniotz; Daisy Acosta; Diana L Matallana; Diego Acosta-Alvear; Dominic Trépel; Elisa De Paula França Resende; Fabricio Ferreira de Oliveira; Francisco Ibanez; Fernanda G De Felice; Gorka Navarrete; Ioannis Tarnanas; Irene B Meier; Jerusa Smid; Jorge Llibre-Guerra; Juan J Llibre-Rodriguez; Laís Fajersztajn; Leonel Tadao Takada; Lissette Duque; Maira Okada de Oliveira; Maria Aparecida Camargos Bicalho; María Isabel Behrens; Maritza Pintado-Caipa; Mario Parra; Maxwell Z Wilson; Myriam De La Cruz Puebla; Nilton Custodio; Rodrigo Santibanez; Rodrigo Bernardo Serafim; Ronnielly Melo Tavares; Stefanie Danielle Piña Escudero; Tomas Leon Rodriguez; Walter Dawson; Bruce L Miller; Kenneth S Kosik
Journal:  Alzheimers Dement (N Y)       Date:  2020-11-23

4.  Late incidence of SARS-CoV-2 infection in a highly-endemic remote rural village. A prospective population-based cohort study.

Authors:  Oscar H Del Brutto; Aldo F Costa; Robertino M Mera; Bettsy Y Recalde; Javier A Bustos; Héctor H García
Journal:  Pathog Glob Health       Date:  2020-09-29       Impact factor: 2.894

5.  Cost effective reproduction number based strategies for reducing deaths from COVID-19.

Authors:  Christopher Thron; Vianney Mbazumutima; Luis V Tamayo; Léonard Todjihounde
Journal:  J Math Ind       Date:  2021-06-28

6.  An Immunoinformatics Approach for SARS-CoV-2 in Latam Populations and Multi-Epitope Vaccine Candidate Directed towards the World's Population.

Authors:  Andrés Felipe Cuspoca; Laura Lorena Díaz; Alvaro Fernando Acosta; Marcela Katherine Peñaloza; Yardany Rafael Méndez; Diana Carolina Clavijo; Juvenal Yosa Reyes
Journal:  Vaccines (Basel)       Date:  2021-06-01

Review 7.  The SARS-CoV-2 Pandemic in Latin America: the Need for Multidisciplinary Approaches.

Authors:  Diana Callejas; José M Echevarría; Yenddy Carrero; Alfonso J Rodríguez-Morales; Ruth Moreira
Journal:  Curr Trop Med Rep       Date:  2020-11-03

8.  The age distribution of mortality from novel coronavirus disease (COVID-19) suggests no large difference of susceptibility by age.

Authors:  Ryosuke Omori; Ryota Matsuyama; Yukihiko Nakata
Journal:  Sci Rep       Date:  2020-10-06       Impact factor: 4.379

9.  Household Clustering of SARS-CoV-2 in Community Settings: A Study from Rural Ecuador.

Authors:  Oscar H Del Brutto; Aldo F Costa; Robertino M Mera; Bettsy Y Recalde; Javier A Bustos; Héctor H García
Journal:  Am J Trop Med Hyg       Date:  2020-09       Impact factor: 2.345

10.  Transmission dynamics and forecasts of the COVID-19 pandemic in Mexico, March-December 2020.

Authors:  Amna Tariq; Juan M Banda; Pavel Skums; Sushma Dahal; Carlos Castillo-Garsow; Baltazar Espinoza; Noel G Brizuela; Roberto A Saenz; Alexander Kirpich; Ruiyan Luo; Anuj Srivastava; Humberto Gutierrez; Nestor Garcia Chan; Ana I Bento; Maria-Eugenia Jimenez-Corona; Gerardo Chowell
Journal:  PLoS One       Date:  2021-07-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.